Robert F. Williamson III is now serving in a new position at BioTheryX, Inc.

Jan 08, 2021
Board and Executive Moves
Background Information
BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY.